Supplement Award Program

HIV/AIDS Related Malignancies

Stimulates research on HIV-associated malignancies to foster multidisciplinary collaborations between Cancer and CFAR investigators by supporting one-year pilot research projects in HIV-associated malignancies. Pilot studies may include basic, translational, and clinical research on the etiology, pathogenesis, prevention, and management of AIDS-defining and non-AIDS-defining malignancies.

HIV-TB Co-infection

Supports a broad range of highly innovative research on: the alterations in HIV pathogenesis and the host immune response in the setting of TB co-infection; TB related immune reconstitution inflammatory syndrome (IRIS); the effect of TB on HIV clinical disease progression, and changes in latent TB activation and/or active disease progression in the setting of antiretroviral therapy.

Nanotechnology and HIV

Supports a broad range of highly innovative, nanotechnology-based research projects in the field of HIV and HIV-related co-infections such as tuberculosis and hepatitis. Technologies to prevent transmission or acquisition of HIV, improve treatment of HIV and its co-infections, and ultimately cure HIV infection are of particular interest.

HIV and Aging

The goal of this funding opportunity is to improve medical outcomes, functional status and quality of life in older patients with HIV/AIDS through improved understanding of interactions among aging processes, HIV viral infection, treatment effects and toxicities, and multiple morbidities commonly occurring in older persons.

HIV Vaccine Discovery

Supports a broad range of highly innovative research in HIV vaccine discovery, including novel assay/technology development, immunology, virology, cellular and structural biology and host genetics, and novel concepts and approaches applicable to the design of an effective prophylactic HIV vaccine.

Outside the Box AIDS Vaccine Award

Stimulates the discovery, design and preclinical evaluation of highly innovative approaches that could provide long term protection from acquiring HIV infection. Applicants are expected to explore novel hypotheses or address difficult problems, the solutions to which could have a significant impact on finding methods to interrupt HIV transmission.

Learn more about current CFAR Supplement Opportunities.

Active Supplement Awards

Krupa Shah Krupa Shah,
Medicine, Geriatrics

Physical Frailty and Sarcopenia in HIV/AIDS Older Adults

Andrea Sant Andrea Sant,
Center for Vaccine Biology and Immunology

Design of optimal multi-epitope vaccines to elicit CD4 T cell immunity to HIV (HIV Vaccine Discovery)

Danielle Benoit Danielle Benoit,
Biomedical Engineering

Using Nanotechnology to Improve Mucosal Delivery of Candidate HIV-1 Vaccines (Nanotechnology and HIV)

Steve Gill Steve Gill,
Microbiology and Immunology

Oral Cavity Squamous Cell Carcinoma and Oral Microbiota in HIV-Positive Individuals (HIV/AIDS Related Malignancies)

Sanjay Maggirwar Sanjay Maggirwar,
Microbiology and Immunology

CD40L connects Aging, HIV-1 and Malignancy (HIV/AIDS Related Malignancies)

Recent Events

2013 World AIDS Day

In honor of World AIDS Day the CFAR hosted a scientific symposium featuring talks from prestigious experts in the AIDS community and research posters from students and post doctoral associates training at the UR.

Congratulations to this year's poster award recipients!
*David Griffith, Departments of Internal Medicine/Pediatrics and Emergency Medicine
*Meera Singh, Department of Microbiology and Immunology
*John DiMaio, Department of Chemistry
*Katherine Thomas, Department of Psychiatry
*Christopher Nishimura, Department of Microbiology and Immunology